Insights

Why Moderna topped the market on Thursday

The company keeps scoring new supply deals across the Pacific.
The post Why Moderna topped the market on Thursday appeared first on The Motley Fool Australia. –

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened

With COVID-19 variants grabbing headlines worldwide, coronavirus stocks are again landing on the radar screens of investors. That, combined with a new supply agreement announced this morning, pushed Moderna‘s (NASDAQ: MRNA) stock up by 0.7% on Thursday, beating the gain of the S&P 500 index on the day.

So what

Moderna is greatly expanding its arrangement with Taiwan. The biotech company has signed on to provide 20 million doses of its mRNA-1273 coronavirus vaccine and its updated variant booster vaccine (if authorized for use) in 2022. This will quadruple the 5 million it is obligated to supply the island nation this year. As part of the new agreement, it will also provide an additional 15 million doses in 2023.

Moderna did not disclose the financial terms of the expanded deal.

It’s the second expansion in Asia announced this week by the company. On Tuesday, it divulged that Japan’s Ministry of Health, Labor and Welfare and Takeda Pharmaceutical will take delivery of 50 million additional doses of the vaccine and, provisionally, the booster, in 2022. That doubles the 50 million already agreed for this year.

Now what

While Moderna frequently makes the headlines as the maker of one of only three coronavirus vaccines authorized for use in the US, mRNA-1273 has the green light in many other jurisdictions around the world, too. The resurgence of COVID-19 isn’t only a US problem, it’s a global issue; therefore, the company will remain on the front lines of the fight as long as it rages.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Why Moderna topped the market on Thursday appeared first on The Motley Fool Australia.

Should you invest $1,000 in Moderna right now?

Before you consider Moderna, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Moderna wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

Australia approves Pfizer vaccine for kids aged 12-15 years old

Here’s why Moderna stock soared 125% during the first 6 months of 2021

Does This Shocking CDC Statement Mean Trouble for Pfizer and Moderna?

With COVID-19 variant threats rising, why are vaccine stocks falling?

Why Moderna shares surged 27% in June

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Moderna Inc. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!